Médecine tropicale : revue du Corps de santé colonial
-
Letter Case Reports
[Guillain-Barré syndrome following type 4 dengue in Polynesia].
Dengue fever is the most frequent arbrovirus infection in the world. It is endemic in French Polynesia where epidemic outbreaks sometimes occur. ⋯ Association of dengue fever with Guillain-Barré syndrome (GBS) has been reported in a few cases. The relationship between these two pathologies is unclear but autoimmune mechanisms are probably involved.
-
Nifurtimox is one of the two molecules used for treatment of Chagas disease. Although posology has not yet been clearly defined, nifurtimox is increasingly used, especially in combination with eflonithin. Nifurtimox is perfectly suited to the WHO's Chagas disease eradication program.
-
Noma causes tissue degeneration of the face resulting in impaired mouth opening with secondary malnutrition and metabolic disorders. Reconstructive plastic surgery for noma can be lifesaving but requires special airway and ventilation techniques because of limited mouth opening. In addition, the African context imposes logistic and budgetary constraints. The purpose of this article is to describe an upper airway management strategy that takes into account disease factors and available resources.
-
Case Reports
[Post-partum thunderclap headaches in a patient from Burkina Faso: reversible cerebral vasoconstriction syndromes].
Reversible cerebral vasoconstriction syndrome (RCVS) is considered as rare but is probably under-recognized. It is characterized by the association of acute severe headache and/or focal neurological deficits and/or seizures and segmental vasoconstriction of cerebral arteries that resolve within one to three months. The purpose of this report is to describe the first case of post-partum RCVS from Burkina Faso. Diagnosis of RCVS was based on clinical setting (post-partum), absence of vascular risk factor, sudden onset, rapid resolution of signs and symptoms within eight days, brain scan findings (spontaneous bilateral posterior low density areas of cerebral ischemia), and elimination of other possible causes, i.e., meningeal or cerebellar hemorrhage, cerebral venous thrombosis, HELLP syndrome.